Related references
Note: Only part of the references are listed.Quantitative Proteomics Reveals Knockdown of CD44 Promotes Proliferation and Migration in Claudin-Low MDA-MB-231 and Hs 578T Breast Cancer Cell Lines
Hyeyoon Kim et al.
JOURNAL OF PROTEOME RESEARCH (2021)
Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update
Joseph A. Clara et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
GGCT promotes colorectal cancer migration and invasion via epithelial-mesenchymal transition
Qi Huang et al.
ONCOLOGY LETTERS (2020)
Rat Bone Marrow-Derived Mesenchymal Stem Cells Promote the Migration and Invasion of Colorectal Cancer Stem Cells
Weiyan Zou et al.
OncoTargets and Therapy (2020)
Targeting Colorectal Cancer Stem Cells as an Effective Treatment for Colorectal Cancer
Yu-Shui Ma et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)
Cancer stem cells: A brief review of the current status
Alican Kusoglu et al.
GENE (2019)
Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
Susu Han et al.
FRONTIERS IN ONCOLOGY (2019)
CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling
Chih-Jen Lai et al.
CELLS (2019)
The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
Zhenpeng Wang et al.
FRONTIERS IN ONCOLOGY (2019)
CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field
Zhan Su et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Cancer stem cell (CSC) resistance drivers
Masoud Najafi et al.
LIFE SCIENCES (2019)
Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells
Yu Hua Quan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Meeting the Challenge of Targeting Cancer Stem Cells
Alice Turdo et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Cancer stem cells in colorectal cancer: a review
Matthew J. Munro et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
The biology and role of CD44 in cancer progression: therapeutic implications
Chen Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
Yun Zhang et al.
FRONTIERS OF MEDICINE (2018)
CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism
Ruifang Gao et al.
THERANOSTICS (2018)
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Marta Prieto-Vila et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Isolation, identification, and characterization of cancer stem cells: A review
Mohammad Reza Abbaszadegan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Prognostic significance of CD24 and CD44 in breast cancer: a meta-analysis
Zhu Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Therapeutic strategies targeting cancer stem cells
Go J. Yoshida et al.
CANCER SCIENCE (2016)
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Dany Nassar et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Cancer stem cells in human gastrointestinal cancer
Hiroaki Taniguchi et al.
CANCER SCIENCE (2016)
CD44: More than a mere stem cell marker
I. Morath et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53
Lin Wang et al.
ONCOLOGY REPORTS (2016)
Cancer stem cell markers: premises and prospects
Madhura Murar et al.
BIOMARKERS IN MEDICINE (2015)
CD44 as a drug delivery target in human cancers: where are we now?
Ibrahim H. Sahin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer
Yunhee Cho et al.
ONCOTARGET (2015)
Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation
Shuo Han et al.
ONCOTARGET (2015)
Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis
Xintao Li et al.
SCIENTIFIC REPORTS (2015)
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
Yongmin Yan et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Colorectal Cancer Stem Cells: From the Crypt to the Clinic
Ann Zeuner et al.
CELL STEM CELL (2014)
CD44 Expression Is Predictive of Poor Prognosis in Pharyngolaryngeal Cancer: Systematic Review and Meta-Analysis
Liang Chai et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2014)
CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression
Aymee Perez et al.
ORAL ONCOLOGY (2013)
Schisandrin B Attenuates Cancer Invasion and Metastasis Via Inhibiting Epithelial-Mesenchymal Transition
Zhen Liu et al.
PLOS ONE (2012)
Colorectal cancer stem cell: a potential therapeutic target
Haiying Tao et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
CD44, a therapeutic target for metastasising tumours
Veronique Orian-Rousseau
EUROPEAN JOURNAL OF CANCER (2010)
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Liqing Jin et al.
NATURE MEDICINE (2006)
A review of oxaliplatin and its clinical use in colorectal cancer
A Grothey et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
CD44: From adhesion molecules to signalling regulators
H Ponta et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Share Paper
